The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies

The goal of the AntiBotABE Program was the development of recombinant antibodies that neutralize botulinum neurotoxins (BoNT) A, B and E. These serotypes are lethal and responsible for most human botulinum cases. To improve therapeutic efficacy, the heavy and light chains (HC and LC) of the three Bo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Christine Rasetti-Escargueil, Arnaud Avril, Sebastian Miethe, Christelle Mazuet, Yagmur Derman, Katja Selby, Philippe Thullier, Thibaut Pelat, Remi Urbain, Alexandre Fontayne, Hannu Korkeala, Dorothea Sesardic, Michael Hust, Michel R. Popoff
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2017-10-01
Col·lecció:	Toxins
Matèries:	AntiBotABE botulinum toxin phage-display IgG neutralization botulism biodefense recombinant oligoclonal antibodies
Accés en línia:	https://www.mdpi.com/2072-6651/9/10/309
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!